Thus, even in the context of this altered proteostatic environment, residual expression levels appear to be a dominant factor in CF variant theratype.5,32 The loss of CANX appears to generally decrease basal expression levels across the spectrum of variants, and the variants that lose their remaining residual expression in knockout cells become desensitized to correctors. Here, CANX is linked to cystic fibrosis.